Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer.
Breast Cancer Res Treat. 2021 Apr;186(3):753-760. doi: 10.1007/s10549-020-06076-5. Epub 2021 Feb 4.
Breast Cancer Res Treat. 2021.
PMID: 33543355
ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor-Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy.
Reinert T, Ramalho S, de Vasconcelos VCA, Silva LR, da Silva AER, de Andrade CA, Kraft MBPL, Coelho GP, Mandelli J, Binotto M, Cabello C, de Paiva Silva GR, Bines J, Barrios CH, Ellis MJ, Graudenz MS.
Reinert T, et al. Among authors: de vasconcelos vca.
Front Oncol. 2020 Apr 3;10:342. doi: 10.3389/fonc.2020.00342. eCollection 2020.
Front Oncol. 2020.
PMID: 32309212
Free PMC article.
Item in Clipboard
Cite
Cite